Case Report

Published on 16 Mar 2023

Pathological fracture due to primary bone lymphoma in a patient with a history of prostate cancer: A case report and review of literature

in Hematologic Malignancies

Pooja Bhakta
Zachary E. Hunzeker
Juan D. Garcia
Ayman Youssef
Bradley J. Grant
Rasha Alfattal
Dylan Weaver
Peeyush Bhargava
Ariel Rischall
Tejo Musunuru

Frontiers in Oncology

doi 10.3389/fonc.2023.1100559

2,211 views

Review

Published on 15 Mar 2023

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis

in Hematologic Malignancies

Valentina Svicher
Romina Salpini
Stefano D’Anna
Lorenzo Piermatteo
Marco Iannetta
Vincenzo Malagnino
Loredana Sarmati

Frontiers in Oncology

doi 10.3389/fonc.2023.1143258

2,200 views
1 citation

Brief Research Report

Published on 15 Mar 2023

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption

in Hematologic Malignancies

Sarah Morin
Federica Giannotti
Anne-Claire Mamez
Amandine Pradier
Stavroula Masouridi-Levrat
Federico Simonetta
Yves Chalandon

Frontiers in Oncology

doi 10.3389/fonc.2023.1095870

2,518 views
4 citations

Case Report

Published on 15 Mar 2023

Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment

in Hematologic Malignancies

Carine Tabak
Stephen Hyter
Abdulraheem Yacoub
Kenneth Byrd
Joseph McGuirk
Andrew K. Godwin
Haitham Abdelhakim

Frontiers in Oncology

doi 10.3389/fonc.2023.1017230

1,773 views

Case Report

Published on 14 Mar 2023

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia

in Hematologic Malignancies

Wei Yuan
Zhen Shang
Kefeng Shen
Qiuxia Yu
Qiuxia Lv
Yang Cao
Jue Wang
Yi Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1066083

1,302 views

Original Research

Published on 14 Mar 2023

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma

in Hematologic Malignancies

Susanne Ghandili
Judith Dierlamm
Carsten Bokemeyer
Clara Marie von Bargen
Sören Alexander Weidemann

Frontiers in Oncology

doi 10.3389/fonc.2023.1146029

1,063 views
1 citation

Review

Published on 14 Mar 2023

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

in Hematologic Malignancies

Giovanni Manfredi Assanto
Ilaria Del Giudice
Irene Della Starza
Roberta Soscia
Marzia Cavalli
Mattia Cola
Vittorio Bellomarino
Mariangela Di Trani
Anna Guarini
Robin Foà

Frontiers in Oncology

doi 10.3389/fonc.2023.1152467

2,329 views
1 citation

Original Research

Published on 10 Mar 2023

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study

in Hematologic Malignancies

Yu-tong Wang
Bin Chu
Tian-guan Zhou
Min-qiu Lu
Lei Shi
Shan Gao
Li-juan Fang
Qiu-qing Xiang
Xin- Zhao
Meng-zhen Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1110693

2,742 views
2 citations

Review

Published on 10 Mar 2023

LSD1 inhibition modulates transcription factor networks in myeloid malignancies

in Hematologic Malignancies

Emily E. Hartung
Kanwaldeep Singh
Tobias Berg

Frontiers in Oncology

doi 10.3389/fonc.2023.1149754

4,075 views
1 citation

Brief Research Report

Published on 10 Mar 2023

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

in Hematologic Malignancies

Gloria Margiotta-Casaluci
Sara Bigliardi
Federica Cocito
Erika Meli
Luigi Petrucci
Maura Nicolosi
Ombretta Annibali
Carola Boccomini
Valentina Bozzoli
Alessia Castellino

Frontiers in Oncology

doi 10.3389/fonc.2023.1120967

3,455 views
2 citations

Editorial

Published on 09 Mar 2023

Editorial: Advances in the treatment of chronic myeloid leukemia

in Hematologic Malignancies

Ahmet Emre Eşkazan
Chung H. Kok
David Yeung
Jignesh Dalal
Mario Tiribelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1166588

2,230 views

Original Research

Published on 09 Mar 2023

A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma

in Hematologic Malignancies

Qiang Zeng
Hang Zhang
Pu Kuang
Jian Li
Xinchuan Chen
Tian Dong
Qiuhui Wu
Chuanli Zhang
Chunping Chen
Ting Niu

Frontiers in Oncology

doi 10.3389/fonc.2023.1143556

1,419 views
1 citation

Editorial

Published on 08 Mar 2023

Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment

in Hematologic Malignancies

Argiris Symeonidis
Ulrich Germing

Frontiers in Oncology

doi 10.3389/fonc.2023.1166163

979 views

Original Research

Published on 07 Mar 2023

Replication stress increases mitochondrial metabolism and mitophagy in FANCD2 deficient fetal liver hematopoietic stem cells

in Hematologic Malignancies

Makiko Mochizuki-Kashio
Noriko Otsuki
Kota Fujiki
Sherif Abdelhamd
Peter Kurre
Markus Grompe
Atsushi Iwama
Kayoko Saito
Ayako Nakamura-Ishizu

Frontiers in Oncology

doi 10.3389/fonc.2023.1108430

1,962 views

Brief Research Report

Published on 07 Mar 2023

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study

in Hematologic Malignancies

S. Chatzileontiadou
E. Hatjiharissi
M. Angelopoulou
J. V. Asimakopoulos
N. E. Loutsidi
T. Chatzikonstantinou
P. Zikos
A. Bouchla
Z. Bezirgiannidou
E. Kouvata

Frontiers in Oncology

doi 10.3389/fonc.2023.1128994

3,712 views
6 citations

Perspective

Published on 07 Mar 2023

Treatment selection for patients with relapsed or refractory follicular lymphoma

in Hematologic Malignancies

Alan Z. Skarbnik
Krish Patel

Frontiers in Oncology

doi 10.3389/fonc.2023.1120358

4,254 views

Navigation group

Articles

Pathological fracture due to primary bone lymphoma in a patient with a history of prostate cancer: A case report and review of literature

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption

Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study

LSD1 inhibition modulates transcription factor networks in myeloid malignancies

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

Editorial: Advances in the treatment of chronic myeloid leukemia

A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma

Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment

Replication stress increases mitochondrial metabolism and mitophagy in FANCD2 deficient fetal liver hematopoietic stem cells

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study

Treatment selection for patients with relapsed or refractory follicular lymphoma